拉丁美洲急性早幼粒细胞白血病的流行病学和治疗。
Epidemiology and treatment of acute promyelocytic leukemia in latin america.
机构信息
National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology/Hematology, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo.
出版信息
Mediterr J Hematol Infect Dis. 2011;3(1):e2011049. doi: 10.4084/MJHID.2011.049. Epub 2011 Oct 24.
Abstract
Distinct epidemiological characteristics have been described in Acute Promielocytic Leukemia (APL). Populations from Latin America have a higher incidence of APL and in some geographic areas a distinct distribution of the PML-RARA isoforms is present. Here, we review the main differences in APL epidemilogy in Latin America as well as treatment outcomes.
摘要
急性早幼粒细胞白血病（APL）具有独特的流行病学特征。拉丁美洲人群的 APL 发病率较高，在某些地理区域，PML-RARA 异构体的分布也存在明显差异。在此，我们回顾了拉丁美洲 APL 流行病学的主要差异以及治疗结果。
相似文献
1
Epidemiology and treatment of acute promyelocytic leukemia in latin america.拉丁美洲急性早幼粒细胞白血病的流行病学和治疗。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011049. doi: 10.4084/MJHID.2011.049. Epub 2011 Oct 24.
2
Modified array-based comparative genomic hybridization detects cryptic and variant PML-RARA rearrangements in acute promyelocytic leukemia lacking classic translocations.改良的基于芯片的比较基因组杂交技术可检测出缺乏经典易位的急性早幼粒细胞白血病中隐匿性和变异型PML-RARA重排。
Diagn Mol Pathol. 2013 Mar;22(1):10-21. doi: 10.1097/PDM.0b013e31825b8326.
3
Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.治疗诱导的早幼粒细胞白血病融合蛋白降解和急性早幼粒细胞白血病的治愈。
Clin Cancer Res. 2009 Oct 15;15(20):6321-6. doi: 10.1158/1078-0432.CCR-09-0209. Epub 2009 Oct 6.
4
Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.急性早幼粒细胞白血病的新型治疗方法：三氧化二砷、维甲酸及类视黄醇药理学
Curr Pharm Biotechnol. 2013;14(9):849-58. doi: 10.2174/1389201015666140113095812.
5
Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.鉴定和监测急性早幼粒细胞白血病中的非典型 PML/RARA 融合转录本。
Genes Chromosomes Cancer. 2019 Jan;58(1):60-65. doi: 10.1002/gcc.22708. Epub 2018 Dec 4.
6
7
Variant and masked translocations in acute promyelocytic leukemia.急性早幼粒细胞白血病中的变异易位和隐匿易位
Leuk Lymphoma. 1996 Jul;22(3-4):221-8. doi: 10.3109/10428199609051752.
8
The epidemiology of acute promyelocytic leukaemia.急性早幼粒细胞白血病的流行病学
Best Pract Res Clin Haematol. 2003 Sep;16(3):357-67. doi: 10.1016/s1521-6926(03)00065-3.
9
PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.PML-RARA-RXR 寡聚体在急性早幼粒细胞白血病细胞分化过程中介导类视黄醇和视黄酸衍生物/cAMP 信号串扰。
J Exp Med. 2004 Apr 19;199(8):1163-74. doi: 10.1084/jem.20032226.
10
Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARalpha fusion gene.起源于拉丁美洲的患者中的急性早幼粒细胞白血病与PML/RARα融合基因的bcr1亚型频率增加有关。
Br J Haematol. 2003 Aug;122(4):563-70. doi: 10.1046/j.1365-2141.2003.04480.x.
引用本文的文献
1
Long-term experience in treatment of acute promyelocytic leukemia in Mexican children in a tertiary care hospital.在一家三级护理医院治疗墨西哥儿童急性早幼粒细胞白血病的长期经验。
Front Oncol. 2023 Nov 7;13:1286106. doi: 10.3389/fonc.2023.1286106. eCollection 2023.
2
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia.端粒重复 RNA 在急性髓系白血病中失调。
Blood Adv. 2023 Nov 28;7(22):7067-7078. doi: 10.1182/bloodadvances.2023010658.
3
Acute promyelocytic leukemia in childhood and adolescence: treatment results of a modified AIDA protocol at a Brazilian center.儿童及青少年急性早幼粒细胞白血病：巴西某中心改良AIDA方案的治疗结果
Hematol Transfus Cell Ther. 2023 Jul;45 Suppl 2(Suppl 2):S126-S130. doi: 10.1016/j.htct.2022.09.1276. Epub 2022 Nov 7.
4
Epidemiology of de novo Acute Myeloid Leukemia in Kuwait per the 2016 WHO Classification.科威特 2016 年世卫组织分类下的新发急性髓系白血病的流行病学。
Med Princ Pract. 2022;31(3):284-292. doi: 10.1159/000524641. Epub 2022 Apr 25.
5
Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study.急性早幼粒细胞白血病后的第二原发性恶性肿瘤：一项基于人群的研究。
Cancers (Basel). 2020 Dec 3;12(12):3610. doi: 10.3390/cancers12123610.
6
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions.发展中国家急性髓细胞白血病治疗的可及性：障碍与解决方案。
Curr Oncol Rep. 2020 Oct 6;22(12):125. doi: 10.1007/s11912-020-00987-8.
7
Myeloid sarcoma of the tongue as a first manifestation of acute promyelocytic leukemia: A case report.舌部髓系肉瘤作为急性早幼粒细胞白血病的首发表现：一例病例报告。
Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):174-177. doi: 10.1016/j.rpor.2019.12.026. Epub 2020 Jan 9.
8
Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia.急性早幼粒细胞白血病的动力学建模及替代治疗策略。
PLoS One. 2019 Aug 15;14(8):e0221011. doi: 10.1371/journal.pone.0221011. eCollection 2019.
9
Cytogenetic abnormalities, WHO classification, and evolution of children and adolescents with acute myeloid leukemia.急性髓系白血病儿童和青少年的细胞遗传学异常、世界卫生组织分类及演变
Hematol Transfus Cell Ther. 2019 Jul-Sep;41(3):236-243. doi: 10.1016/j.htct.2018.09.007. Epub 2019 Feb 16.
10
A simplified approach using Taqman low-density array for medulloblastoma subgrouping.采用 Taqman 低密度基因芯片进行髓母细胞瘤亚组分类的简化方法。
Acta Neuropathol Commun. 2019 Mar 4;7(1):33. doi: 10.1186/s40478-019-0681-y.
本文引用的文献
1
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.急性早幼粒细胞白血病的持续高早期死亡率：来自瑞典成人急性白血病登记处的一项基于人群的报告。
Leukemia. 2011 Jul;25(7):1128-34. doi: 10.1038/leu.2011.78. Epub 2011 Apr 19.
2
Childhood leukemia incidence in Brazil according to different geographical regions.巴西不同地区儿童白血病的发病率。
Pediatr Blood Cancer. 2011 Jan;56(1):58-64. doi: 10.1002/pbc.22736.
3
Treatment outcome of acute promyelocytic leukemia with modified aida protocol.采用改良阿依达方案治疗急性早幼粒细胞白血病的疗效
Adv Hematol. 2010;2010:672137. doi: 10.1155/2010/672137. Epub 2010 May 16.
4
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.基于全反式维甲酸和蒽环类药物联合阿糖胞苷巩固治疗高危患者的急性早幼粒细胞白血病的风险适应性治疗：治疗结果的进一步改善。
Blood. 2010 Jun 24;115(25):5137-46. doi: 10.1182/blood-2010-01-266007. Epub 2010 Apr 14.
5
Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador.萨尔瓦多儿童急性白血病治疗相关死亡率的发生率及预测因素
Br J Cancer. 2009 Apr 7;100(7):1026-31. doi: 10.1038/sj.bjc.6604895. Epub 2009 Mar 17.
6
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.急性早幼粒细胞白血病的管理：代表欧洲白血病网的专家小组建议
Blood. 2009 Feb 26;113(9):1875-91. doi: 10.1182/blood-2008-04-150250. Epub 2008 Sep 23.
7
Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital.儿童急性早幼粒细胞白血病：巴西一家儿童医院的全反式维甲酸治疗
J Pediatr Hematol Oncol. 2008 May;30(5):387-90. doi: 10.1097/MPH.0b013e3181662493.
8
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.接受全反式维甲酸和伊达比星治疗的急性早幼粒细胞白血病患者缓解诱导失败的原因及预后因素
Blood. 2008 Apr 1;111(7):3395-402. doi: 10.1182/blood-2007-07-100669. Epub 2008 Jan 14.
9
Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.134例接受全反式维甲酸和蒽环类药物治疗的巴西急性早幼粒细胞白血病患者的临床特征与预后
Haematologica. 2007 Oct;92(10):1431-2. doi: 10.3324/haematol.10874.
10
Impact of an education program on late diagnosis of retinoblastoma in Honduras.一项教育计划对洪都拉斯视网膜母细胞瘤晚期诊断的影响。
Pediatr Blood Cancer. 2007 Nov;49(6):817-9. doi: 10.1002/pbc.21052.
Zotero 插件